Sequencing Considerations in mCRPC
CARD Trial: Safety and Efficacy of Cabazitaxel in mCRPC & Age Subgroup Analysis
By
Dana-Farber Cancer Institute
FEATURING
Atish Choudhury
By
Dana-Farber Cancer Institute
FEATURING
Atish Choudhury
Comments 0
Login to view comments.
Click here to Login